KaliVir Immunotherapeutics
Develops oncolytic immunotherapies for patients with advanced solid tumors
$14MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops oncolytic immunotherapies for patients with advanced solid tumors
Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues
Pitching SV Investment? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room